Perceptive Advisors’s Hologic HOLX Stock Holding History

Perceptive Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-25,000	Closed	-$559K	–	136
2013 Q4	$559K	Buy	+25,000	New	+$551K	0.07%	75

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Perceptive Advisors's HOLX Position: Q4 2020 in Review

Perceptive Advisors sold out of Hologic (HOLX) in Q4 2020, closing a stake of 170,000 shares — an estimated $11.3M sold.

Perceptive Advisors first reported a position in HOLX in Q1 2016 and held it in 3 quarters. The position peaked at $13.1M in Q2 2020. 629 funds tracked by Wall St. Rank hold HOLX as of Q4 2020.

Perceptive Advisors reported no remaining Hologic position as of Q4 2020 after selling out during the quarter.
Perceptive Advisors sold 170,000 Hologic shares in Q4 2020, an estimated $11.3M.
Perceptive Advisors first reported a position in Hologic in Q1 2016 and held it in 3 quarters.
Perceptive Advisors's Hologic position peaked at $13.1M in Q2 2020.
629 funds tracked by Wall St. Rank held Hologic as of Q4 2020.

Based on Perceptive Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.